Qpex Biopharma Finds $33M For Antibiotics Development
OCTOBER 22, 2018
According to Qpex, the funding was led by New Enterprise Associates, and also included Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Draper Fund. The company also said it has an agreement with the Biomedical Advanced Research and Development Authority (BARDA), worth up to a total award of $132M. Qpex says it is developing new antibiotics to combat the threat of global antimicrobial resistance.